Compare Alliant Energy Corporation (LNT) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alliant Energy Corporation vs Recursion Pharmaceuticals Inc — how do they compare? Alliant Energy Corporation trades at $73.98 (market cap $19.10B), while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: Alliant Energy Corporation is far larger — about 12.5× Recursion Pharmaceuticals Inc's market cap, and Alliant Energy Corporation pays a 2.89% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| LNT | RXRX | |
|---|---|---|
Market Cap | $19.10B | $1.53B |
Sector | Utilities | Health |
52-Week High | $78.03 | $6.79 |
52-Week Low | $63.62 | $2.84 |
Enterprise Value | $30.83B | $946.50M |
Dividend Yield | 2.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Alliant Energy (LNT) trades at $73.11, down 2.29% on the day, with a bullish technical outlook and strong analyst support. The stock shows steady revenue growth, improving net income margins to 18.58% in 2025, and consistent dividend payments. Recent news highlights its $13.4 billion clean energy investment plan targeting 5-7% annual earnings growth, driven by data center demand and grid modernization initiatives.
LNT presents a favorable risk-reward profile with a consensus price target of $78.50, offering 7.4% upside. Key risks include rising debt levels and execution of capital-intensive projects. The bullish analyst consensus (52% Buy) and institutional confidence support long-term growth, though investors should monitor interest rate sensitivity and regulatory developments.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
